Short Dental Implants (5 mm) Versus Long Dental Implants (10 mm)

Sponsor
University of Michigan (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT04144322
Collaborator
(none)
34
1
2
42.5
0.8

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the survival rate of 5 mm short implants compared to longer implants (10 mm) placed in sinus-grafted sites.

Primary aim: Compare bone loss between the two groups Secondary aim: Compare surgical time and patient-reported outcomes (satisfaction and post-operative pain)

Condition or Disease Intervention/Treatment Phase
  • Device: Zimmer T3 Short Ex Hex With Discrete Crystalline Deposition
  • Device: Zimmer T3 with DCD Ex Hex Parallel Walled implants
N/A

Detailed Description

34 patients requiring an implant to replace an upper missing tooth in the premolar or 1st molar area with a bone crest height from 5 to 8 mm will be recruited for this trial. Patients will be randomized to either the test (5-mm implant) or control group (10-mm implant) using a computer-generated randomization list . 17 patients will receive a sinus lift procedure, bone graft, and 10 mm implant while the other 17 patients will receive a 5 mm short implant.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
34 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Short Dental Implants (5 mm) Versus Long Dental Implants (10 mm) in Combination With Sinus Floor Elevation: A Randomized Clinical Trial
Actual Study Start Date :
Oct 14, 2019
Anticipated Primary Completion Date :
Apr 30, 2023
Anticipated Study Completion Date :
Apr 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Other: Short Implant

17 patients will receive a 5 mm short implant.

Device: Zimmer T3 Short Ex Hex With Discrete Crystalline Deposition
Placement of a short implant

Other: Long Implant

17 patients will receive a sinus lift procedure, bone graft, and 10 mm implant.

Device: Zimmer T3 with DCD Ex Hex Parallel Walled implants
Placement of a long implant with sinus lift and bone graft

Outcome Measures

Primary Outcome Measures

  1. Change in mesial-distal (M-D) bone loss [Baseline, surgical visit 1 day, 4 months, 5 months, 12 months, 24 months]

    Comparing mesial-distal (M-D) bone loss between the two groups. This will be measured in millimeters using standardized radiographs of the implant site at the screening visit, surgical visit, 4 months post-op, 5 months post-op, 12 months post-op, and 24 months post-op visits.

Secondary Outcome Measures

  1. Survival rate [5 month post-op, 12 month post-op, and 24 month post-op visits]

    The survival rate of the two groups will be recorded as a percentage at the 5 month post-op, 12 month post-op, and 24 month post-op visits based on clinician assessment.

  2. Number of sites with bleeding on probing [5 month post-op, 12 month post-op, and 24 month post-op visits]

    The number of sites with bleeding on probing will be compared between the two groups. Bleeding on probing of the implant site will be measured with a periodontal probe at the 5 month post-op, 12 month post-op, and 24 month post-op visits.

  3. Probing pocket depth [5 month post-op, 12 month post-op, and 24 month post-op visits]

    The probing pocket depths will be compared between the two groups. Probing depths of the implant site will be measured with a periodontal probe at the 5 month post-op, 12 month post-op, and 24 month post-op visits.

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Age 20-70 years at enrollment

  • Systemically healthy patients

  • Full-mouth plaque score and full-mouth bleeding score ≤ 30% (measured at four sites per tooth)

  • In need of one premolar or 1st molar dental implant in the maxillary area

  • Neighboring teeth to the planned implant must have natural root(s) or implant supported restoration.

  • Presence of natural tooth/teeth, partial prosthesis and/or implants in the opposite jaw in contact with the planned crown/s deemed by the investigator as likely to present an initially stable implant situation

  • Residual bone height under the maxillary sinus between 5 to 7 mm and a width of at least 7 mm, as measured on cone beam computer tomography (CBCT) scans.

Exclusion Criteria:
  • Unlikely to be able to comply with study procedures

  • Uncontrolled pathologic processes in the oral cavity

  • History of head and neck chemotherapy within 5 years prior to surgery

  • Systemic or local disease or condition that could compromise post-operative healing and/or osseointegration

  • Uncontrolled diabetes mellitus HbA1c >8

  • Taking corticosteroids, IV bisphosphonates, or any other medication that could influence post-operative healing and/or osseointegration

  • Smokes more than 10 cigarettes/day

  • Bruxer

  • Present alcohol and/or drug abuser

  • Pregnant, unsure pregnancy status, or lactating females (self-reported)

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Michigan School of Dentistry Ann Arbor Michigan United States 48109

Sponsors and Collaborators

  • University of Michigan

Investigators

  • Principal Investigator: Tae-Ju Oh, University of Michigan

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Tae-Ju Oh, Clinical Professor of Dentistry, University of Michigan
ClinicalTrials.gov Identifier:
NCT04144322
Other Study ID Numbers:
  • HUM00151047
First Posted:
Oct 30, 2019
Last Update Posted:
Nov 15, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 15, 2021